Ashok Reddy, the core's director, is a bioanalytical chemist and manages proteomics projects across the entire university. He has 14 years of experience conducting cancer research including the world's largest cancer dose response study and 19 years of experience conducting proteomics/biomarker discovery studies in cell cultures, tissues, exosomes, human body fluids, such as serum, saliva, cervico-vaginal fluid (CVF), cerebrospinal fluid (CSF), amniotic fluid, and urine. He has managed large cancer and proteomics projects from conception to discovery as demonstrated by the successful discovery of biomarkers of infection for Pre-term birth and Preeclampsia. His work with protein biomarkers led to venture capital investment of $20 million for his former employer Proteogenix, Inc. His research interests are in disease biomarkers in body fluids and tumor markers in cancer tissues.
Larry David, the core's faculty advisor, is a protein chemist with over 10 years of experience studying proteins using mass spectrometry. His research interests include studying age-related modifications in proteins by mass spectrometry, and in addition to acting as a faculty advisor to the core is a principal investigator conducting NIH sponsored research.
Phillip Wilmarth is an informatics expert who received his Ph.D. under the direction of the Nobel Laureate Glenn Seaborg. He has worked in the David lab and proteomics core since 2003, and during that time has co-authored 32 peer-reviewed manuscripts providing informatics expertise for a wide range of proteomics experiments. He is an avid bicyclist and enjoys spending time with his wife and cats.
Keith Zientek is an analytical chemist with 20 years in experience in mass spectrometry. Before coming to OHSU he ran a bioanalytical and biophysical core at the Portland Shriners Hospital for Children. He has experience in small molecule analysis including time spent working in veterinary forensics and clinical drug trials.